These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Increasing the dose of ibuprofen with postnatal age to close a hemodynamically significant patent ductus arteriosus in very preterm infants. Carneiro L, Bouissou A, Favrais G. Eur J Pediatr; 2023 Aug; 182(8):3527-3535. PubMed ID: 37204599 [Abstract] [Full Text] [Related]
23. Oral ibuprofen is superior to oral paracetamol for patent ductus arteriosus in very low and extremely low birth weight infants. Lu J, Li Q, Zhu L, Chen C, Li Z. Medicine (Baltimore); 2019 Aug; 98(31):e16689. PubMed ID: 31374055 [Abstract] [Full Text] [Related]
25. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Ohlsson A, Walia R, Shah SS. Cochrane Database Syst Rev; 2013 Apr 30; (4):CD003481. PubMed ID: 23633310 [Abstract] [Full Text] [Related]
26. Oral versus intravenous paracetamol for patent ductus arteriosus closure in preterm infants. Gover A, Levy PT, Rotschild A, Golzman M, Molad M, Lavie-Nevo K, Kessel I. Pediatr Res; 2022 Oct 30; 92(4):1146-1152. PubMed ID: 35087197 [Abstract] [Full Text] [Related]
28. Paracetamol for patent ductus arteriosus in preterm infants: a UK national survey. Noureldein M, Hu K, Groucutt J, Heaver R, Gurusamy K. J Matern Fetal Neonatal Med; 2022 Apr 30; 35(7):1408-1411. PubMed ID: 32290734 [Abstract] [Full Text] [Related]
30. Intravenous paracetamol with a lower dose is also effective for the treatment of patent ductus arteriosus in pre-term infants. Tekgündüz KŞ, Ceviz N, Caner İ, Olgun H, Demirelli Y, Yolcu C, Şahin İO, Kara M. Cardiol Young; 2015 Aug 30; 25(6):1060-4. PubMed ID: 25160728 [Abstract] [Full Text] [Related]
34. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study. Heyman E, Morag I, Batash D, Keidar R, Baram S, Berkovitch M. Pediatrics; 2003 Nov 30; 112(5):e354. PubMed ID: 14595076 [Abstract] [Full Text] [Related]
35. Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. Oncel MY, Yurttutan S, Erdeve O, Uras N, Altug N, Oguz SS, Canpolat FE, Dilmen U. J Pediatr; 2014 Mar 30; 164(3):510-4.e1. PubMed ID: 24359938 [Abstract] [Full Text] [Related]
37. Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment. Yoo H, Lee JA, Oh S, Jung YH, Sohn JA, Shin SH, Choi CW, Kim EK, Kim HS, Kim BI. J Korean Med Sci; 2017 Jan 30; 32(1):115-123. PubMed ID: 27914140 [Abstract] [Full Text] [Related]
38. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Ohlsson A, Walia R, Shah S. Cochrane Database Syst Rev; 2005 Oct 19; (4):CD003481. PubMed ID: 16235321 [Abstract] [Full Text] [Related]
39. [Risk factors for the failure of ibuprofen treatment in preterm infants with hemodynamically significant patent ductus arteriosus]. Wu ZQ, Zhang Y, Zhou QQ, Liu Q, Cheng S, Xia SW. Zhongguo Dang Dai Er Ke Za Zhi; 2024 Apr 15; 26(4):343-349. PubMed ID: 38660897 [Abstract] [Full Text] [Related]
40. Value of near-infrared spectroscopy in monitoring intestinal tissue oxygen saturation in preterm infants with hemodynamically significant patent ductus arteriosus: a prospective research. Huang XB, Zhong X, Liu T, Cheng GQ, Qiu HX. Zhongguo Dang Dai Er Ke Za Zhi; 2021 Aug 15; 23(8):821-827. PubMed ID: 34511172 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]